Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Longwood Management LLC

Longwood Management LLC

Institutional venture firmBoston, MAlongwoodfund.comSEC venture capital fund adviserone firm, 2 filing advisers

This firm files as 2 advisers on longwoodfund.com: Longwood Fund Management LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

Investing where Discovery becomes Patient Care As life science venture investors, industry connectors, and company founders, Longwood Fund identifies and

venture manager, reported GAV $450M across 12 vehicles

Importance
47
elevated
Active deployment
55
elevated
Emerging
0
low
Completeness
75
high
Freshness
100
high
Research priority
20
moderate
Identity and regulatory footprint
Headquarters
Boston, MAadviserinfo.sec.gov
Office address
800 BOYLSTON ST, SUITE 1715, Boston, MA, 02199adviserinfo.sec.gov
Business phone
617-351-2590adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 31, 2026
Private funds reported
12 (12 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$456Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
617-351-2590adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
17 observed deals
Stated (the firm’s website)
Sectors
biotech
Stages
growth
Geography
boston
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 17
Funds and vehicles
12 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Longwood Special Situations Fund, L.P.Fund2024 form d first saleEarly deployment$0
Mar 25, 2024
0$158M
of $200M
Dec 19, 2024
Lf-A Incubator Fund, L.P.Feeder or parallel2023 adv first reportedActive deployment$38.9M
Mar 25, 2024
1unknownunknown
Lf-Cff Incubator Fund II, L.P.Fund2022 adv first reportedActive deployment$23.8M
Mar 25, 2024
1unknownunknown
Longwood Fund VI, L.P.Fund2021 form d first saleMature$112M
Mar 25, 2024
25$94.5M
of $150M
Sep 22, 2022
Lf-B Incubator Fund, LLCFeeder or parallel2021 adv first reportedMature$30.3M
Mar 25, 2024
1unknownunknown
Lf-Cff Incubator Fund, L.P.Fund2021 adv first reportedMature$19.6M
Mar 25, 2024
1unknownunknown
Lfshv, LLCFund2021 adv first reportedMature$4,623
Mar 25, 2024
14unknownunknown
Longwood Fund V, LPFund2019 form d first saleMature$117M
Mar 25, 2024
39$118M
of $118M
Jul 1, 2020
Longwood Fund IV, LPFund2017 adv first reportedHarvest$30.2M
Mar 25, 2024
18unknownunknown
Longwood Fund II LPFund2012 form d first saleHarvest$23.3M
Mar 25, 2024
30$66.7M
of $80.0M
May 15, 2014
Longwood Fund LPFund2010 form d first saleHarvest$19.0M
Mar 25, 2024
52$86.9M
of $86.9M
Dec 27, 2010
Longwood Fund III, LPFundunknownUnknown$35.8M
Mar 25, 2024
45$0
of $90.0M
Apr 30, 2015
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
26 current, 3 departed
Barry Greene
CEO (former), Sage Therapeutics; President (former), Alnylam
Founder or executive
Fiona Marshall
President, BioMedical Research, Novartis
Founder or executive
John Maraganore
CEO (former), Alnylam; Chair (former), BIO
Founder or executive
K. Dane Wittrup
MIT, Koch; Scientific Co-Founder: Adimab, Immunitas
Founder or executive
Paul Schimmel
NAS; Scripps; Co-Founder: Alnylam; SAB: Momenta, Sirtris
Founder or executive
Phil Sharp
Nobel Laureate; NAS; Co-Founder: Biogen, Alnylam SAB: Sirtris, Verastem
Founder or executive
Stephen Elledge
Gregor Mendel Professor of Genetics and of Medicine, Harvard ; Lasker Award-winner, HHMI Co-Founder, TScan
Founder or executive
3 departed (kept with end dates)
Investments on record
17 edges, 17 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
AAVantgarde Bioportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Be Biopharmaportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Coultreonportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
getfusedportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Industry Eventsportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more AAVantgarde Bioportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Alnaraportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more ArcherDXportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Avenzoportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more BBOTportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Be Biopharmaportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Bicycle Therapeuticsportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Calithera Biosciencesportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Carbon Biosciencesportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Channel MedSystemsportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Colorescienceportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Learn more Coultreon Biopharmaportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
3 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
21 dated events
  1. Mar 25, 2024
    John Edward Lawrence (Other Executive Officer) no longer on Schedule A of Longwood Management LLC
  2. Mar 25, 2024
    Longwood Special Situations Fund, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund)
  3. Mar 31, 2023
    Lf-A Incubator Fund, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $40,000,000
  4. Apr 1, 2022
    Joshua O'Brien Lubov joined Schedule A of Longwood Management LLC as Chief Financial Officer
  5. Mar 10, 2022
    Longwood Fund VI, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $90,413,283
  6. Mar 10, 2022
    Lf-Cff Incubator Fund II, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $25,000,000
  7. Mar 15, 2021
    Lfshv, LLC first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $2,111
  8. Mar 15, 2021
    Longwood Fund, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $19,477,864
  9. Mar 15, 2021
    Lf-B Incubator Fund, LLC first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $29,292,659
  10. Mar 15, 2021
    Longwood Fund II, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $44,078,053
  11. Mar 15, 2021
    Lf-Cff Incubator Fund, L.P. first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $19,689,148
  12. Feb 28, 2020
    Longwood Fund V, LP first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $70,111,750
  13. Jan 1, 2020
    David a Steinberg joined Schedule A of Longwood Management LLC as Other Executive Officer
  14. Apr 25, 2018
    Robert Owen Hadfield (General Counsel) no longer on Schedule A of Longwood Management LLC
  15. Mar 28, 2018
    Brian Patrick Malone (Chief Financial Officer) no longer on Schedule A of Longwood Management LLC
  16. Nov 1, 2017
    John Edward Lawrence joined Schedule A of Longwood Management LLC as Chief Financial Officer
  17. Nov 1, 2017
    Robert Owen Hadfield joined Schedule A of Longwood Management LLC as General Counsel
  18. Mar 15, 2017
    Longwood Fund IV, LP first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $57,000,000
  19. Aug 14, 2015
    Longwood Management LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
  20. Aug 14, 2015
    Longwood Fund III, LP first reported on Form ADV by Longwood Management LLC (Venture Capital Fund), GAV $81,000,000
  21. Aug 1, 2015
    Richard H. (mi Only) Aldrich joined Schedule A of Longwood Management LLC as Other Executive Officer
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $450M across 12 vehicles
Evidence
53 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2015-08-14Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-31Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-25Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2015-08-14Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone617-351-2590Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone617-351-2590Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionInvesting where Discovery becomes Patient Care As life science venture investors, industry connectors, and company founders, Longwood Fund identifies and
meta description
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBoston, MAMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersBoston, MAMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address800 BOYLSTON ST, SUITE 1715, Boston, MA, 02199Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address800 BOYLSTON ST, SUITE 1715, Boston, MA, 02199Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
We leverage our curated network of industry leaders across academia, medicine, pharma, biotech, and venture capital to inform every stage of our investing process: from identifying and evaluating cutt
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited Liability CompanyMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.longwoodfund.com/portfolio
17 entries read
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported12Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported12Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$456MMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$450MMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyboston
geography words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesgrowth
stage words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.longwoodfund.com/team
22 name/title pairs read
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported12Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported12Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTPS://LONGWOODFUND.COMMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTPS://LONGWOODFUND.COMMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Website statusunreachable
home page did not answer with HTML
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleHome - Longwood Fund
title tag
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)